U.S. Markets closed

Supernus Pharmaceuticals, Inc. (SUPN)


NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
41.85-2.25 (-5.10%)
At close: 4:00PM EDT

41.85 0.00 (0.00%)
After hours: 6:46PM EDT

People also watch
SCMPPCRXOMERPTLAIRWD
  • Did anyone hear the brief blurb on Bloomberg radio, Friday afternoon, June 23, about a venture firm being in talks with Supernus regarding a potential buy out?
  • Harry Boxer has posted his Charts of the Day video on SUPN at TheTechTrader site noting: Supernus Pharmaceuticals, Inc. (SUPN) has been a wonderful, long-term biotech stock, going from 9.00 to 43.00. It formed a wedge, popped out of the wedge, and ran 1.35, or 3%, to 42.75, on 579,086 shares traded on Wednesday. It may get a pullback in this zone, but if it accelerates, I’m looking for 40-50 as the next target. It has 5 days to cover .
  • Inopi beneficium bis opportune datus est.http://dataunion.tistory.com/8496

    Supernus Pharmaceuticals Inc NASDAQ $SUPN Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks Sep-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is -0.6 In other words, the correlation coefficient of the other stoc
    dataunion.tistory.com
  • Thanks for the tip, I did some research and found more information about $SUPN on http://squeezereport.com/?s=SUPN "rht" Day trading investing.

    Squeeze Report | Stock Trading Predictive Algorithm Identifying Potential Gains
    Stock trading predictive short and long algorithm services for the novice to expert investor.
    squeezereport.com
  • Mydayis finally approved... ?single-digit? royalty. If GtN is good, should bring in 10 m or so to the bottom line over time...
  • Do you think this thing is done selling? Showing us a buy signal now on SUPN? check out awe_some_stock_s, its a pretty reliable service. of course you have to do your own due diligence, but they generally point you in the right direction.
  • In the short-term SUPN does not seem to be like a good trade. if you guys have questions you should ask awesome.stock.s. They often respond to my emails which is helpful.
  • Harry Boxer has posted his Charts of the Day video on SUPN at TheTechTrader site noting:
    Supernus Pharmaceuticals, Inc. (SUPN) had a very nice session on Wednesday, jumping 2.20, or 6.2%, to 37.60, on 1.15 million shares traded. It’s trending nicely. My near-term target is 39-40, followed by 48-50 eventually.
  • Shareholder since 2012 at $6.25. Anybody know where this thing is going? I took some profits today at $36, but holding out for more with the rest.
  • Piper Jaffray: Oxtellar seen gaining ground in the bipolar segment, significant revenue increase for SUPN

    http://www.investors.com/news/technology/this-top-rated-biotech-just-popped-to-a-record-high-on-an-upgrade/

    This Top-Rated Biotech Just Popped To A Record High On An Upgrade
    Supernus' second-biggest moneymaker could grab FDA approval to treat bipolar disorder, an analyst suggested Thursday, prompting shares to a record high.
    www.investors.com
  • Love this ride up and more to go once SPN 810 and 812 get approved. Question to solid shareholders: What are the odds of a buy-out by a major pharma such as Pfizer, Allergan, Sanofi and/or Shire etc?
  • don't know if you are still out there Sam, but hope you stayed put.
    Have a great holiday...
    luck
  • Earnings per share for the first quarter of 2017 includes an effective tax rate of 36.5%.
    The effective tax rate of 4.0% during the first quarter of 2016.
  • NEW Interview out on AQS.V , this micro cap with a market cap of ridiculous $11 Million will hit breakeven by year end . This undiscovered stock is a lifetime opportunity for those who have patience

    http://biotech-tv.com/c/mid,1770,OnDemand/?v=297513

    Aequus Pharmaceuticals: Fast Growing Specialty Pharma Company From Canada | Biotech-TV
    Biotech-TV
    biotech-tv.com
  • Harry Boxer has posted his Charts of the Day video on SUPN at TheTechTrader site noting: Supernus Pharmaceuticals, Inc. (SUPN) reached a new all-time high on Wednesday, running 60 cents, or 2%, to 32.45, on 609,772 shares traded. It may be headed to 36-7, my next target.
  • Harry Boxer has posted his Charts of the Day video on SUPN at TheTechTrader site noting: Supernus Pharmaceuticals, Inc. (SUPN) popped out of a little wedge on Tuesday. It didn’t close great, but it was still up 60 cents, or 2%, to 31.85, on 532,147 shares traded. It looks to me like it wants to go up to the 35-6, maybe even the 37 range. It has 3.9 days to cover.
  • U have news NOW... whats it worth ie stock price with this news ...? any est...?
  • Anyone know why the big run up?
  • Harry Boxer has posted his Charts of the Day video on SUPN at TheTechTrader site noting: Supernus Pharmaceuticals, Inc. (SUPN) broke out of a new 17-year, all-time high, on Monday, jumping 85 cents, or 2.8%, to 30.80, on 865,869 shares traded, reaching 31.33. It’s in a beautiful rising channel, and looks like it will reach up to at least 35-37. It has 6.5 days to cover, so that may happen. There are rumors, though, that there’s a possible secondary on this one.